Literature DB >> 11875178

Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies.

Jennifer A Olson1, Donald M Olson, Christy Sandborg, Steven Alexander, Bruce Buckingham.   

Abstract

A 6-year-old boy presented with epilepsia partialis continua 6 months after diagnosis of type 1 diabetes. Anti-glutamic acid decarboxylase 65 antibodies were found in his serum and cerebrospinal fluid. Anti-epileptic agents did not improve his seizures. High-dose steroids, plasmapheresis, and intravenous immunoglobulin resulted in decreased anti-glutamic acid decarboxylase 65 antibody levels and resolution of his seizures.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11875178     DOI： 10.1542/peds.109.3.e50

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


  9 in total

1.  Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Authors:  Esther Ganelin-Cohen; Dalit Modan-Moses; Rina Hemi; Hannah Kanety; Bruria Ben-Zeev; Christiane S Hampe
Journal:  Pediatr Diabetes       Date:  2015-12-29       Impact factor: 4.866

Review 2.  Diabetes and epilepsy in children and adolescents.

Authors:  M Loredana Marcovecchio; Marianna Immacolata Petrosino; Francesco Chiarelli
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

3.  Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study.

Authors:  I-Ching Chou; Chung-Hsing Wang; Wei-De Lin; Fuu-Jen Tsai; Che-Chen Lin; Chia-Hung Kao
Journal:  Diabetologia       Date:  2016-03-31       Impact factor: 10.122

4.  Epilepsia partialis continua in type 1 diabetes: evolution into epileptic encephalopathy with continuous spike-waves during slow sleep.

Authors:  Maria Giuseppina Baglietto; Maria Margherita Mancardi; Alessandro Giannattasio; Nicola Minuto; Andrea Rossi; Giuseppe Capovilla; Edvige Veneselli; Renata Lorini; Giuseppe d'Annunzio
Journal:  Neurol Sci       Date:  2009-08-15       Impact factor: 3.307

5.  Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism.

Authors:  Kathleen Connery; Marie Tippett; Leanna M Delhey; Shannon Rose; John C Slattery; Stephen G Kahler; Juergen Hahn; Uwe Kruger; Madeleine W Cunningham; Craig Shimasaki; Richard E Frye
Journal:  Transl Psychiatry       Date:  2018-08-10       Impact factor: 6.222

6.  Continuous Visual Focal Status Epilepticus as the Primary Presentation of NMDA-R and GAD65-R Autoimmune Epilepsy.

Authors:  Elma M Paredes-Aragón; Héctor E Valdéz-Ruvalcaba; Andrea Santos-Peyret; Marcela Cisneros-Otero; Raúl Medina-Rioja; Sandra Orozco-Suárez; Miriam M Hernandez; Michele D L Breda-Yepes; Verónica Rivas-Alonso; José J Flores-Rivera; Iris E Martínez-Juárez
Journal:  Front Neurol       Date:  2020-11-26       Impact factor: 4.003

7.  Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.

Authors:  Changhong Ren; Haitao Ren; Xiaotun Ren; Weihua Zhang; Jiuwei Li; Lifang Dai; Hongzhi Guan; Fang Fang
Journal:  Front Neurol       Date:  2021-04-12       Impact factor: 4.003

8.  GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Authors:  Suvi Liimatainen; Jerome Honnorat; Sean J Pittock; Andrew McKeon; Mario Manto; Jared R Radtke; Christiane S Hampe
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.123

9.  Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?

Authors:  Tao-Ran Li; Yu-Di Zhang; Qun Wang; Xiao-Qiu Shao; Zhi-Mei Li; Rui-Juan Lv
Journal:  BMC Neurosci       Date:  2020-03-30       Impact factor: 3.288
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.